Today is August 30, 2024.
All times in Eastern Daylight Time.
-
Fastly Announces Second Quarter 2024 Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Fastly Announces Second Quarter 2024 Financial Results more »
-
Sinclair Reports Second Quarter 2024 Financial Results
BALTIMORE--(BUSINESS WIRE)--Sinclair, Inc. (Nasdaq: SBGI), the "Company" or "Sinclair," today reported financial results for the three and six months ended June 30, 2024. Highlights: Met second qua... more »
-
Alpha and Omega Semiconductor Reports Financial Results for Fiscal Fourth Quarter and Fiscal Year Ended June 30, 2024
SUNNYVALE, Calif.--(BUSINESS WIRE)--Alpha and Omega Semiconductor Reports Financial Results for Fiscal Fourth Quarter and Fiscal Year Ended June 30, 2024 more »
-
Blue Bird Announces CEO and Chairman Transition Plan
MACON, Ga.--(BUSINESS WIRE)--Blue Bird Corporation (Nasdaq: BLBD), the leader in electric and low-emission school buses, today announced that Britton Smith will assume the position of President &am... more »
-
Biodesix Announces Second Quarter 2024 Results and Highlights
LOUISVILLE, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced its financial and operating results for the second quarter ended June 30, ... more »
-
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the “company” or “Viridian”), a biopharmaceutical company focused on discovering and developing potential best-in-class ... more »
-
Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights more »
-
Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update more »
-
Insight to Present at Oppenheimer 27th Annual Technology, Internet & Communications Conference
CHANDLER, Ariz.--(BUSINESS WIRE)--Insight Enterprises, Inc. (Nasdaq: NSIT) (the “Company”) today announced that it is scheduled to participate in the following upcoming investor conference: Oppenhe... more »
-
Harrow Announces Second Quarter 2024 Financial Results
NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the second quarter and six months ended June 30, 2024. The C... more »
-
Palladyne AI Corp Provides Mid-Year Business and Financial Update
SALT LAKE CITY--(BUSINESS WIRE)--Palladyne AI Corp. (NASDAQ: PDYN and PDYNW) (“Palladyne AI”), a developer of artificial intelligence software for robotic platforms in the commercial and defense se... more »
-
Atara Biotherapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to dev... more »
-
Personalis Reports Second Quarter 2024 Financial Results
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the second quarter ended June 30, 2024,... more »
-
Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 3 Dry Eye Chamber Clinical Trial of Reproxalap
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced it will host a webcast and conference call on Thursday, August 8, 2024, at 9:00 a.m. (ET) to p... more »
-
STAAR Surgical Reports Second Quarter 2024 Results
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, ... more »
-
Alpha and Omega Semiconductor to Participate in Upcoming Investor Conferences
SUNNYVALE, Calif.--(BUSINESS WIRE)--Alpha and Omega Semiconductor to Participate in Upcoming Investor Conferences more »
-
CSG Systems International Reports Second Quarter 2024 Results
DENVER--(BUSINESS WIRE)--CSG (NASDAQ: CSGS) today reported results for the quarter ended June 30, 2024. Exciting Customer Wins including Telenor Denmark, Telstra, One New Zealand & Lyse Norway ... more »
-
Performant Financial Corporation Announces Financial Results for Second Quarter 2024
PLANTATION, Fla.--(BUSINESS WIRE)--Performant Financial Corporation (Nasdaq: PFMT), a leading provider of healthcare payment integrity services, today reported the following financial results for i... more »
-
FIVE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Five Below, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Fiv... more »
-
Cirrus Logic to Present at Upcoming Conference
AUSTIN, Texas--(BUSINESS WIRE)--Cirrus Logic, Inc. (Nasdaq: CRUS) announced that President and Chief Executive Officer John Forsyth will present at the Oppenheimer Technology, Internet & Commun... more »
-
BARK Reports First Quarter Fiscal Year 2025 Results
NEW YORK--(BUSINESS WIRE)--BARK, Inc. (NYSE: BARK) (“BARK” or the “Company”), a leading global omnichannel dog brand with a mission to make all dogs happy, today announced its financial results for... more »
-
UPDATED TIME: Forge Global Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7th, 2024
SAN FRANCISCO--(BUSINESS WIRE)--Forge Global Holdings, Inc. (“Forge”) (NYSE: FRGE), a leading provider of marketplace infrastructure, data services and technology solutions for private market parti... more »
-
Invenra Highlights Exelixis’ Announcement: Initiation of Phase 1 Clinical Trial Evaluating XB010 in Patients with Advanced Solid Tumors
MADISON, Wisc.--(BUSINESS WIRE)--Invenra’s collaboration partner, Exelixis, Inc. (NASDAQ: EXEL) has announced the initiation of the dose-escalation stage of the first-in-human phase 1 clinical tria... more »
-
AM Best Affirms Credit Ratings of CICA Life Insurance Company of America
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb+” (Good) of CICA Life Insurance Company of America (C... more »
-
Logix Biosciences, Inc. Announces Appointment of Amy Broidrick to Board of Directors
MONTEREY, Calif.--(BUSINESS WIRE)--Logix Biosciences, a biopharmaceutical company focused on the discovery and development of a pipeline of precision therapeutics and companion diagnostics for alle... more »
|
|